NCT04907409View on ClinicalTrials.gov

Home OCT Fluid Visualization Agreement Study

UnknownOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

June 17, 2021

Primary Completion Date

July 30, 2022

Study Completion Date

August 30, 2022

Conditions
Neovascular Age-related Macular Degeneration
Trial Locations (7)

21061

RECRUITING

Elman Retina Group, P.A., Glen Burnie

23230

RECRUITING

Virginia Eye Institute, Richmond

23502

RECRUITING

Wagner Macula & Retina Center, Norfolk

30060

RECRUITING

Georgia Retina, Marietta

40509

RECRUITING

Retina Associates of Kentucky, Lexington

63017

RECRUITING

Pepose Vision Institute/Midwest Vision Research Foundation, Chesterfield

02114

RECRUITING

Ophthalmic Cons. of Boston, Boston

Sponsors

Lead Sponsor

Notal Vision Inc.
All Listed Sponsors
lead

Notal Vision Inc.

INDUSTRY

NCT04907409 - Home OCT Fluid Visualization Agreement Study | Biotech Hunter | Biotech Hunter